Abuse Potential and Pharmacodynamic Characteristics of Oral and Intranasal Eluxadoline, a Mixed μ- and κ-Opioid Receptor Agonist and δ-Opioid Receptor Antagonist

Drugs with μ-opioid receptor (OR) activity can be associated with abuse and misuse. The peripherally acting mixed μ-OR and κ-OR agonist and δ-OR antagonist eluxadoline is approved in the United States for the treatment of irritable bowel syndrome with diarrhea. In two separate crossover studies, we...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Pharmacol Exp Ther
Autores principales: Levy-Cooperman, N., McIntyre, G., Bonifacio, L., McDonnell, M., Davenport, J. M., Covington, P. S., Dove, L. S., Sellers, E. M.
Formato: Artigo
Lenguaje:Inglês
Publicado: The American Society for Pharmacology and Experimental Therapeutics 2016
Materias:
Behavioral Pharmacology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5118645/
https://ncbi.nlm.nih.gov/pubmed/27647873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.116.236547
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares